White Pine Capital Has Decreased Its Myriad Genetics (MYGN) Position; Comerica (CMA) Shorts Up By 0.75%

January 14, 2018 - By Clifton Ray

Comerica Incorporated (NYSE:CMA) had an increase of 0.75% in short interest. CMA’s SI was 3.01M shares in January as released by FINRA. Its up 0.75% from 2.98 million shares previously. With 1.49 million avg volume, 2 days are for Comerica Incorporated (NYSE:CMA)’s short sellers to cover CMA’s short positions. The stock increased 0.56% or $0.52 during the last trading session, reaching $93.04. About 1.62M shares traded or 1.40% up from the average. Comerica Incorporated (NYSE:CMA) has risen 54.07% since January 14, 2017 and is uptrending. It has outperformed by 37.37% the S&P500.

White Pine Capital Llc decreased Myriad Genetics Inc (MYGN) stake by 51.17% reported in 2017Q3 SEC filing. White Pine Capital Llc sold 10,465 shares as Myriad Genetics Inc (MYGN)’s stock rose 13.21%. The White Pine Capital Llc holds 9,985 shares with $361,000 value, down from 20,450 last quarter. Myriad Genetics Inc now has $2.50 billion valuation. The stock increased 1.46% or $0.52 during the last trading session, reaching $36.05. About 670,506 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since January 14, 2017 and is downtrending. It has underperformed by 54.17% the S&P500.

Since September 1, 2017, it had 0 insider buys, and 3 insider sales for $1.36 million activity. Another trade for 7,500 shares valued at $248,925 was made by GILBERT WALTER PHD on Thursday, December 14. 30,000 Myriad Genetics, Inc. (NASDAQ:MYGN) shares with value of $909,040 were sold by HENDERSON JOHN T. $201,000 worth of Myriad Genetics, Inc. (NASDAQ:MYGN) was sold by DREISMANN HEINRICH on Monday, December 11.

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.16, from 1.02 in 2017Q2. It is negative, as 33 investors sold MYGN shares while 72 reduced holdings. 28 funds opened positions while 62 raised stakes. 71.79 million shares or 8.95% less from 78.85 million shares in 2017Q2 were reported. Alliancebernstein Limited Partnership has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Albert D Mason Inc holds 0.48% in Myriad Genetics, Inc. (NASDAQ:MYGN) or 16,322 shares. Aperio Ltd Liability Corporation accumulated 11,732 shares. Moreover, Mitsubishi Ufj Trust Banking Corporation has 0.03% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 461,559 shares. Parkside Natl Bank And Trust has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). First Trust Advsrs LP stated it has 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Credit Suisse Ag has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Nuveen Asset Mgmt Ltd Limited Liability Company accumulated 12,904 shares. Vanguard Incorporated stated it has 6.33M shares. Moreover, Moors And Cabot has 0.11% invested in Myriad Genetics, Inc. (NASDAQ:MYGN). Pnc Financial Svcs has 3,217 shares. Michigan-based Comerica Natl Bank has invested 0.03% in Myriad Genetics, Inc. (NASDAQ:MYGN). State Farm Mutual Automobile Insur owns 404,728 shares. Bancshares Of Mellon holds 0.01% in Myriad Genetics, Inc. (NASDAQ:MYGN) or 907,166 shares. Fisher Asset Mngmt Ltd Liability accumulated 120,312 shares or 0.01% of the stock.

White Pine Capital Llc increased Ishares Core Total Us Bond Mkt Etf (AGG) stake by 500 shares to 8,045 valued at $881.65M in 2017Q3. It also upped Financial Select Sector Spdr F (XLF) stake by 10,900 shares and now owns 21,800 shares. Vanguard Ftse Emerging Markets Etf (VWO) was raised too.

Analysts await Myriad Genetics, Inc. (NASDAQ:MYGN) to report earnings on February, 6. They expect $0.24 EPS, down 7.69% or $0.02 from last year’s $0.26 per share. MYGN’s profit will be $16.62 million for 37.55 P/E if the $0.24 EPS becomes a reality. After $0.26 actual EPS reported by Myriad Genetics, Inc. for the previous quarter, Wall Street now forecasts -7.69% negative EPS growth.

Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 4 Sell and 12 Hold. Therefore 20% are positive. Myriad Genetics had 50 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, June 12 by Jefferies. Piper Jaffray maintained the shares of MYGN in report on Thursday, July 13 with “Hold” rating. The rating was maintained by Piper Jaffray on Tuesday, September 15 with “Overweight”. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) has “Hold” rating given on Monday, August 14 by Cowen & Co. The stock has “Neutral” rating by Ladenburg Thalmann on Wednesday, February 8. The stock has “Market Outperform” rating by Avondale on Wednesday, May 4. The firm has “Hold” rating given on Friday, October 20 by Jefferies. The stock has “Neutral” rating by PiperJaffray on Wednesday, August 10. The company was maintained on Friday, September 15 by Cowen & Co. As per Wednesday, November 8, the company rating was maintained by Morgan Stanley.

Among 32 analysts covering Comerica Inc (NYSE:CMA), 15 have Buy rating, 2 Sell and 15 Hold. Therefore 47% are positive. Comerica Inc had 110 analyst reports since July 20, 2015 according to SRatingsIntel. As per Monday, November 28, the company rating was upgraded by Jefferies. BMO Capital Markets maintained the shares of CMA in report on Tuesday, October 3 with “Hold” rating. On Wednesday, January 20 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Tuesday, October 11, the company rating was downgraded by FBR Capital. The firm earned “Buy” rating on Sunday, October 15 by Piper Jaffray. Wedbush maintained it with “Neutral” rating and $61 target in Wednesday, November 30 report. The firm has “Hold” rating given on Monday, January 8 by SunTrust. The firm earned “Neutral” rating on Thursday, April 21 by Bank of America. Piper Jaffray maintained Comerica Incorporated (NYSE:CMA) on Monday, December 28 with “Neutral” rating. The firm has “Outperform” rating given on Wednesday, July 20 by RBC Capital Markets.

Comerica Incorporated, through its subsidiaries, provides various financial services and products. The company has market cap of $16.18 billion. The firm operates through three divisions: Business Bank, Retail Bank, and Wealth Management. It has a 21.08 P/E ratio. The Business Bank segment offers various services and products, such as commercial loans and lines of credit, deposits, cash management, capital market products, international trade finance, letters of credit, foreign exchange management, and loan syndication services to middle market businesses, multinational firms, and governmental entities.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>